CSL Archives -

As the landscape of healthcare changes, so too must the way that we interpret and measure performance and

Omnichannel Benchmarking: a new era of HCP engagement

https://pharmaphorum.com/sales-marketing/omnichannel-benchmarking-a-new-era-of-hcp-engagement/

Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in an all-cash deal

Australia’s CSL makes $11.7bn bid for Swiss pharma Vifor

https://pharmaphorum.com/news/australias-csl-makes-11-7bn-bid-for-swiss-pharma-vifor/

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies

After Celgene deal, BMS shoots up pharma market cap rankings

https://pharmaphorum.com/news/after-celgene-deal-bms-shoots-up-pharma-market-cap-rankings/

US operations pull in revenues

Australia’s CSL on the rise as profits increase 30%

https://pharmaphorum.com/news/australias-csl-rise-profits-increase-30/

CSL